The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer
Open accessAbstract
The five-year survival rate of epithelial ovarian cancer (EOC) is approximately 35–40% despite maximal treatment efforts, highlighting a need for stratification biomarkers for personalized treatment. Here we extract 657 quantitative mathematical descriptors from the preoperative CT images of 364 EOC patients at their initial presentation. Using machine learning, we derive a non-invasive summary-statistic of the primary ovarian tumor based on 4 descriptors, which we name “Radiomic Prognostic Vector” (RPV). RPV reliably identifies the 5% of patients with median overall survival less than 2 years, significantly improves established prognostic methods, and is validated in two independent, multi-center cohorts. Furthermore, genetic, transcriptomic and proteomic analysis from two independent datasets elucidate that stromal phenotype and DNA damage response pathways are activated in RPV-stratified tumors. RPV and its associated analysis platform could be exploited to guide personalized therapy of EOC and is potentially transferrable to other cancer types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
Aerts, H. J. W. L., Velazquez, E. R., Leijenaar, R. T. H., Parmar, C., Grossmann, P., Carvalho, S., Bussink, J., Monshouwer, R., Haibe-Kains, B., Rietveld, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5006 · Cited by 5,132
The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository
Clark, K., Vendt, B., Smith, K., Freymann, J., Kirby, J., Koppel, P., Moore, S., Phillips, S., Maffitt, D., Pringle, M., et al. (2013) · Journal of Digital Imaging · doi:10.1007/s10278-013-9622-7 · Cited by 4,599
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
McShane, L. M., Altman, D. G., Sauerbrei, W., Taube, S. E., Gion, M., & Clark, G. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji237 · Cited by 2,162
A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme
Lao, J., Chen, Y., Li, Z.-C., Li, Q., Zhang, J., Liu, J., & Zhai, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10649-8 · Cited by 630
Decoding global gene expression programs in liver cancer by noninvasive imaging
Segal, E., Sirlin, C. B., Ooi, C., Adler, A. S., Gollub, J., Chen, X., Chan, B. K., Matcuk, G. R., Barry, C. T., Chang, H. Y., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1306 · Cited by 629
Research works printed but not linked: 46
- Aerts, H. J. The potential of radiomic-based phenotyping in precision edicine: a review. JAMA Oncol. 2, 1636–1642 (2016). · DOI · Paper page
- Nougaret, S. et al. High-grade serous ovarian cancer: associations between BRCA mutation status, CT imaging phenotypes, and clinical outcomes. Radiology 285, 472–481 (2017). · DOI
- Vargas, H. A. et al. Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study. Radiology 274, 742–751 (2015). · DOI
- Heinzmann, K., Carter, L. M., Lewis, J. S. & Aboagye, E. O. Multiplexed imaging for diagnosis and therapy. Nat. Biomed. Eng. 1, 697–713 (2017). · DOI · Paper page
- Agarwal, R. & Kaye, S. B. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer 3, 502–516 (2003). · DOI · Paper page
- Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer 11, 719–725 (2011). · DOI · Paper page
- Etemadmoghadam, D. et al. Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin. Cancer Res. 15, 1417–1427 (2009). · DOI · Paper page
- Patch, A. M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489–494 (2015). · DOI · Paper page
- Verhaak, R. G. et al. Prognostically relevant gene signatures of high-grade serous ovarian carcinoma. J. Clin. Invest. 123, 517–525 (2013).
- Leong, H. S. et al. Efficient molecular subtype classification of high-grade serous ovarian cancer. J. Pathol. 236, 272–277 (2015). · DOI
- Tothill, R. W. et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 14, 5198–5208 (2008). · DOI · Paper page
- Bagnoli, M. et al. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study. Lancet Oncol. 17, 1137–1146 (2016). · DOI
- Arshad, M. A. et al. Discovery of pre-therapy 2-deoxy-2-(18)F-fluoro-D-glucose positron emission tomography-based radiomics classifiers of survival outcome in non-small-cell lung cancer patients. Eur. J. Nucl. Med. Mol. Imaging 46, 455–466 (2019). · DOI
- Cancer Genome Atlas Research, N. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011). · DOI · Paper page
- Tibshirani, R. The lasso method for variable selection in the Cox model. Stat. Med. 16, 385–395 (1997). · doi:10.1002/(sici)1097-0258(19970228)16:4<385::aid-sim380>3.0.co;2-3
- Harrell, F. E. Jr., Lee, K. L. & Mark, D. B. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 15, 361–387 (1996). · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
- Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518–527 (2008). · DOI · Paper page
- Malhotra, D. et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat. Immunol. 13, 499–510 (2012). · DOI · Paper page
- Gaillard, H., Garcia-Muse, T. & Aguilera, A. Replication stress and cancer. Nat. Rev. Cancer 15, 276–289 (2015). · DOI · Paper page
- Wei, S. H. et al. Prognostic DNA methylation biomarkers in ovarian cancer. Clin. Cancer Res. 12, 2788–2794 (2006). · DOI
- Macintyre, G. et al. Copy-number signatures and mutational processes in ovarian carcinoma. bioRxiv https://doi.org/10.1101/174201 (2017). · DOI
- Parkinson, C. A. et al. Exploratory analysis of TP53 mutations in circulating tumour DNA as biomarkers of treatment response for patients with relapsed high-grade serous ovarian carcinoma: a retrospective study. PLoS Med. 13, e1002198 (2016). · DOI · Paper page
- De Fauw, J. et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat. Med. 24, 1342–1350 (2018). · DOI · Paper page
- Busuttil, R. A. et al. A signature predicting poor prognosis in gastric and ovarian cancer represents a coordinated macrophage and stromal response. Clin. Cancer Res. 20, 2761–2772 (2014). · DOI
- Zhang, S. Z. et al. Stroma-associated master regulators of molecular subtypes predict patient prognosis in ovarian cancer. Sci. Rep.-Uk 5, 16066 (2015). · DOI
- Chen, P. et al. Identification of prognostic groups in high-grade serous ovarian cancer treated with platinum-taxane chemotherapy. Cancer Res. 75, 2987–2998 (2015). · DOI
- Chen, J. L. Y. et al. Stromal responses among common carcinomas correlated with clinicopathologic features. Clin. Cancer Res. 19, 5127–5135 (2013). · DOI
- Bonome, T. et al. Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res. 65, 10602–10612 (2005). · DOI · Paper page
- Wang, L. M. et al. The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget 7, 4183–4194 (2016). · DOI
- Mo, F. et al. Stromal gene expression is predictive for metastatic primary prostate cancer. Eur. Urol. 73, 524–532 (2018). · DOI
- Isella, C. et al. Stromal contribution to the colorectal cancer transcriptome. Nat. Genet. 47, 312–319 (2015). · DOI · Paper page
- Frings, O. et al. Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling. Am. J. Pathol. 182, 2037–2047 (2013). · DOI
- Mhawech-Fauceglia, P. et al. Stromal expression of fibroblast activation protein alpha (FAP) predicts platinum resistance and shorter recurrence in patients with epithelial ovarian cancer. Cancer Microenviron. 8, 23–31 (2015). · DOI · Paper page
- Davidson, B., Trope, C. G. & Reich, R. The role of the tumor stroma in ovarian cancer. Front. Oncol. 4, 104 (2014).
- Sherman-Baust, C. A. et al. Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells. Cancer Cell 3, 377–386 (2003). · DOI · Paper page
- Wang, W. et al. Effector T cells abrogate stroma-mediated chemoresistance in ovarian. Cancer Cell. 165, 1092–1105 (2016).
- Kristensen, V. N. et al. Principles and methods of integrative genomic analyses in cancer. Nat. Rev. Cancer 14, 299–313 (2014). · DOI · Paper page
- Jena, R. et al. A novel algorithm for the morphometric assessment of radiotherapy treatment planning volumes. Br. J. Radiol. 83, 44–51 (2010). · doi:10.1259/bjr/27674581
- Cook, G. J. R. et al. Are pretreatment F-18-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J. Nucl. Med. 54, 19–26 (2013). · DOI · Paper page
- Cheng, N. M. et al. Textural features of pretreatment F-18-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma. J. Nucl. Med. 54, 1703–1709 (2013). · DOI
- Amadasun, M. & King, R. Textural features corresponding to textural properties. IEEE T. Syst. Man Cyb. 19, 1264–1274 (1989). · DOI · Paper page
- Cheng, N. M. et al. Zone-size nonuniformity of F-18-FDG PET regional textural features predicts survival in patients with oropharyngeal cancer. Eur. J. Nucl. Med. Mol. I 42, 419–428 (2015). · DOI
- Hatt, M. et al. F-18-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J. Nucl. Med. 56, 38–44 (2015). · DOI · Paper page
- Tibes, R. et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol. Cancer Ther. 5, 2512–2521 (2006). · DOI · Paper page
- Bell, D. et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609–615 (2011). · DOI · Paper page
- Yeung, T. L. et al. TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 73, 5016–5028 (2013). · DOI · Paper page
Cited by
Zwanenburg, A., Vallières, M., Abdalah, M. A., Aerts, H. J. W. L., Andrearczyk, V., Apte, A., Ashrafinia, S., Bakas, S., Beukinga, R. J., Boellaard, R., et al. (2020) · Radiology · doi:10.1148/radiol.2020191145 · Cited by 4,177
Secure, privacy-preserving and federated machine learning in medical imaging
Kaissis, G. A., Makowski, M. R., Rückert, D., & Braren, R. F. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-0186-1 · Cited by 1,676
Swarm Learning for decentralized and confidential clinical machine learning
Warnat-Herresthal, S., Schultze, H., Shastry, K. L., Manamohan, S., Mukherjee, S., Garg, V., Sarveswara, R., Händler, K., Pickkers, P., Aziz, N. A., et al. (2021) · Nature · doi:10.1038/s41586-021-03583-3 · Cited by 884
Artificial intelligence in cancer diagnosis and prognosis: Opportunities and challenges
Huang, S., Yang, J., Fong, S., & Zhao, Q. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.12.007 · Cited by 672
The Ethics of Artificial Intelligence: Principles, Challenges, and Opportunities
Floridi, L. (2023) · doi:10.1093/oso/9780198883098.001.0001 · Cited by 507
Metadata
- Authors
- Lu, H., Arshad, M., Thornton, A., Avesani, G., Cunnea, P., Curry, E., Kanavati, F., Liang, J., Nixon, K., Williams, S. T., Hassan, M. A., Bowtell, D. D. L., Gabra, H., Fotopoulou, C., Rockall, A., & Aboagye, E. O.
- Venue
- Nature Communications
- Published
- 2019-02-15
- Volume
- 10
- Issue
- 1
- Pages
- 764-764
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2913823430
- Cited by
- 212
- References
- 11
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer. https://app.cochat.ai/papers/10.1038/s41467-019-08718-9
- The paper
- Lu, H., Arshad, M., Thornton, A., Avesani, G., Cunnea, P., Curry, E., Kanavati, F., Liang, J., Nixon, K., Williams, S. T., Hassan, M. A., Bowtell, D. D. L., Gabra, H., Fotopoulou, C., Rockall, A., & Aboagye, E. O. (2019). A mathematical-descriptor of tumor-mesoscopic-structure from computed-tomography images annotates prognostic- and molecular-phenotypes of epithelial ovarian cancer. Nature Communications. https://doi.org/10.1038/s41467-019-08718-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.